Please Note: Microsoft has ended support of its older browsers as of January 2016. If you are seeing this message, you are viewing the site on an unsupported version of Internet Explorer (IE10 or older). To properly view this website, please upgrade your version of IE or access this site using a different browser. Thank you.
Sign InDues Join Privacy Contact Search
Home News APCR Response to Speaker Pelosi's Proposed Medicare Changes

News

APCR Response to Speaker Pelosi's Proposed Medicare Changes

posted: September 19, 2019

House Speaker Nancy Pelosi released a plan today on changes to the way the U.S. values and reimburses prescription drugs, including in the Medicare program, which will have significant impacts on clinical research in the future. The plan would enable direct price negotiation on up to 250 drugs, implement new liabilities in the Medicare program, new price controls, and the hammer of a 65-95% new tax. These policies will impact investment in clinical research and innovation may suffer as a result. The Academy of Physicians in Clinical Research (APCR) released the following statement regarding the proposed changes.

Read the Full Letter